| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.14T | 1.03T | 1.03T | 1.03T | 761.82B | 553.96B |
| Gross Profit | 123.61B | 121.25B | 129.62B | 125.90B | 90.72B | 64.84B |
| EBITDA | 36.74B | 43.29B | 71.77B | 64.14B | 40.77B | 18.70B |
| Net Income | 20.99B | 25.28B | 48.07B | 41.03B | 25.80B | 10.88B |
Balance Sheet | ||||||
| Total Assets | 652.00B | 556.44B | 552.24B | 517.62B | 362.58B | 269.59B |
| Cash, Cash Equivalents and Short-Term Investments | 48.04B | 48.53B | 38.71B | 37.57B | 25.17B | 25.44B |
| Total Debt | 73.25B | 75.92B | 64.86B | 55.32B | 59.16B | 32.05B |
| Total Liabilities | 373.24B | 294.96B | 295.82B | 309.86B | 182.82B | 123.58B |
| Stockholders Equity | 268.60B | 252.41B | 244.31B | 199.79B | 170.13B | 142.18B |
Cash Flow | ||||||
| Free Cash Flow | 23.36B | 22.57B | 38.58B | 37.90B | -16.47B | 37.32B |
| Operating Cash Flow | 25.30B | 24.23B | 39.95B | 38.90B | -15.53B | 38.08B |
| Investing Cash Flow | -175.00M | -7.96B | -18.46B | -869.00M | -1.65B | -2.18B |
| Financing Cash Flow | -23.05B | -5.84B | -23.01B | -27.10B | 14.37B | -26.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥60.34B | 10.45 | ― | 2.87% | 10.24% | 61.61% | |
76 Outperform | ¥302.36B | 15.35 | 5.77% | 3.28% | 11.15% | -19.39% | |
70 Outperform | ¥70.90B | 15.74 | 5.37% | 3.41% | -12.80% | 4.26% | |
66 Neutral | ¥88.69B | 8.78 | ― | 2.41% | 16.05% | 3.58% | |
64 Neutral | ¥428.71B | 14.59 | ― | 2.87% | 8.99% | -43.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥109.10B | 43.14 | ― | 2.45% | 4.60% | -21.64% |